Inflammatory bowel disease aggregation in Utah kindreds

Inflammatory Bowel Diseases

Volumn 17, Issue 3, 2011, Pages 823-830

  Guthery, Stephen L ^a   Mineau, Geraldine ^a,b   Pimentel, Richard ^b   Williams, Marc S ^c   Kerber, Richard A ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c INTERMOUNTAIN HEALTHCARE   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Crohn's disease; genealogy and heredity; genetic epidemiology; genetic predisposition to disease; inflammatory bowel disease; pedigree; ulcerative colitis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE EXACERBATION; FAMILIAL DISEASE; FEMALE; HERITABILITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ULCERATIVE COLITIS; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UTAH;

EID: 79951643930     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21390     Document Type: Article

References (52)

1. Maher B,. Personal genomes: the case of the missing heritability. Nature. 2008; 456: 18-21.
2. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009; 461: 747-753.
3. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40: 955-962.
4. Barrett JC, Lee JC, Lees CW, et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet. 2009: 41: 1330-1334.
5. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314: 1461-1463. (Pubitemid 44871953)
6. Fisher S, Tremelling M, Anderson C, et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet. 2008; 40: 710-712. (Pubitemid 351748865)
7. Franke A, Balschun T, Karlsen TH, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008; 40: 1319-1323.
8. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007; 39: 207-211. (Pubitemid 46184351)
9. Imielinski M, Baldassano RN, Griffiths A, et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet. 2009; 41: 1335-1340.
10. Kugathasan S, Baldassano RN, Bradfield JP, et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet. 2008; 40: 1211-1215.
11. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007; 39: 830-832. (Pubitemid 47014496)
12. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007; 39: 596-604. (Pubitemid 46676115)
13. Silverberg MS, Cho JH, Rioux JD, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet. 2009; 41: 216-220.
14. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447: 661-678.
15. Bodmer W, Bonilla C,. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet. 2008; 40: 695-701. (Pubitemid 351748875)
16. Schork NJ, Murray SS, Frazer KA, et al. Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev. 2009; 19: 212-219.
17. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009; 361: 2033-2045.
18. Kerber RA,. Method for calculating risk associated with family history of a disease. Genet Epidemiol. 1995; 12: 291-301.
19. Wylie JE, Mineau GP,. Biomedical databases: protecting privacy and promoting research. Trends Biotechnol. 2003; 21: 113-116. (Pubitemid 36293767)
20. Norlin C, Osborn LM,. Organizational responses to managed care: issues for academic health centers and implications for pediatric programs. Pediatrics. 1998; 101: 805-811; discussion 811-802.
21. Ward L, Ashdown N,. Census brief: age distribution in Utah. Second in a Series of Census 2000 Analyses. 2001. Available at
22. Economists I,. Competition in Utah health care markets: report to the Privately Owned Health Care Organization Task Force of the Utah Legislature. 2006: 1-101.
23. Bai Y, Sherman S, Khoury MJ, et al. Bias associated with study protocols in epidemiologic studies of disease familial aggregation. Am J Epidemiol. 2000; 151: 927-937. (Pubitemid 30461134)
24. Huber PJ,. The behavior of maximum likelihood estimates under non-standard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability Vol 1. 1967: 221-233.
25. White H,. A heteroskedasticity-consistent covariace matrix estimator and a direct test for heteroscedasticity. Econometrica. 1980; 48: 817-830.
26. Bruzzi P, Green SB, Byar DP, et al. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985; 122: 904-914. (Pubitemid 16207356)
27. Boucher KM, Kerber RA,. Measures of familial aggregation as predictors of breast-cancer risk. J Epidemiol Biostat. 2001; 6: 377-385. (Pubitemid 33134097)
28. Kerber RA, O'Brien E, Smith KR, et al. Familial excess longevity in Utah genealogies. J Gerontol A Biol Sci Med Sci. 2001; 56: B130-139. (Pubitemid 32187136)
29. Kerber RA, O'Brien E,. A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer. 2005; 103: 1906-1915. (Pubitemid 40563264)
30. Padayachee M, Feighery C, Finn A, et al. Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT. Genomics. 1992; 14: 551-553.
31. Lander ES, Schork NJ,. Genetic dissection of complex traits. Science. 1994; 265: 2037-2048. (Pubitemid 24325685)
32. Gusev A, Lowe JK, Stoffel M, et al. Whole population, genome-wide mapping of hidden relatedness. Genome Res. 2009; 19: 318-326.
33. Thomas A, Camp NJ, Farnham JM, et al. Shared genomic segment analysis. Mapping disease predisposition genes in extended pedigrees using SNP genotype assays. Ann Hum Genet. 2008; 72: 279-287. (Pubitemid 351228466)
34. Houwen RH, Baharloo S, Blankenship K, et al. Genome screening by searching for shared segments: mapping a gene for benign recurrent intrahepatic cholestasis. Nat Genet. 1994; 8: 380-386. (Pubitemid 24375605)
35. Berkovic SF, Dibbens LM, Oshlack A, et al. Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am J Hum Genet. 2008; 82: 673-684.
36. Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A. 2009; 106: 19096-19101.
37. Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet. 2010; 42: 30-35.
38. Ng SB, Turner EH, Robertson PD, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature. 2009; 461: 272-276.
39. Meucci G, Vecchi M, Torgano G, et al. Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group). Gastroenterology. 1992; 103: 514-519.
40. Monsen U, Brostrom O, Nordenvall B, et al. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol. 1987; 22: 214-218. (Pubitemid 17024407)
41. Probert CS, Jayanthi V, Hughes AO, et al. Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut. 1993; 34: 1547-1551. (Pubitemid 23341846)
42. Reynisdottir I, Gudbjartsson DF, Johannsson JH, et al. A genetic contribution to inflammatory bowel disease in Iceland: a genealogic approach. Clin Gastroenterol Hepatol. 2004; 2: 806-812. (Pubitemid 39200719)
43. Kyle J,. Crohn's disease in the northeastern and northern Isles of Scotland: an epidemiological review. Gastroenterology. 1992; 103: 392-399.
44. Montgomery SM, Morris DL, Thompson NP, et al. Prevalence of inflammatory bowel disease in British 26 year olds: national longitudinal birth cohort. BMJ. 1998; 316: 1058-1059. (Pubitemid 28143104)
45. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999; 149: 916-924. (Pubitemid 29230706)
46. Herrinton LJ, Liu L, Lafata JE, et al. Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis. 2007; 13: 451-461. (Pubitemid 46668251)
47. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007; 5: 1424-1429. (Pubitemid 350181588)
48. Loftus EV,. The burden of inflammatory bowel disease in the United States: a moving target? Clin Gastroenterol Hepatol. 2007; 5: 1383-1384.
49. McLellan T, Jorde LB, Skolnick MH,. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet. 1984; 36: 836-857. (Pubitemid 14030098)
50. Xing J, Watkins WS, Witherspoon DJ, et al. Fine-scaled human genetic structure revealed by SNP microarrays. Genome Res. 2009; 19: 815-825.
51. (CDC). CfDCaP. Behavioral Risk Factor Surveillance System Survey Questionnaire.: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008.
52. Benchimol E, Guttmann A, Griffiths A, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut. 2009; 58: 1490-1497.